Close Menu

NEW YORK – Clinical lab firm Genova Diagnostics has agreed to pay approximately $43 million to resolve allegations that it violated the False Claims Act, including allegations that it billed federal health insurance programs for medically unnecessary tests.

The US Department of Justice announced the settlement Monday. Under the terms of the deal, Asheville, North Carolina-based Genova will surrender $17 million in claims funds held by Medicare and TRICARE and pay up to another $26 million contingent upon certain financial events occurring in the next five years.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.


As worldwide COVID-19 cases continue to rise, there is a significant need to increase testing and population surveillance capacity.

Sponsored by

This webinar will present a case study from in vitro diagnostics developer SpeeDx on its experience building a complete sample-to-result workflow — encompassing instrumentation and data analysis software — for its qPCR-based ResistancePlus MG Mycoplasma genitalium assay.